Silexion Therapeutics (SLXN) Retained Earnings (2023 - 2026)
Silexion Therapeutics (SLXN) posted quarterly Retained Earnings of $58.1 million for Q1 2026, up 22.24% year-over-year from $47.6 million in Q1 2025, and up 0.72% quarter-over-quarter from $57.7 million in Q4 2025.
Silexion Therapeutics (SLXN) Retained Earnings (2023 - 2026) Analysis & Trends
Silexion Therapeutics' Retained Earnings history runs 4 years deep, the most recent figure standing at $58.1 million for Q1 2026.
- In Q1 2026, Retained Earnings rose 22.24% year-over-year to $58.1 million; the TTM figure through Mar 2026 stood at $58.1 million (up 22.24% YoY), while the FY2025 annual figure was $57.7 million, up 47.03% from the prior year.
- Retained Earnings for Q1 2026 stood at $58.1 million, up from $57.7 million in the prior quarter.
- The five-year high for Retained Earnings was $58.1 million in Q1 2026, with the low at -$50.8 million in Q3 2025.
- The 4-year median for Retained Earnings is $39.3 million (2024), against an average of $24.6 million.
- Peak annual rise in Retained Earnings reached 317.65% in 2025, while the deepest fall reached 237.16% in 2025.
- Silexion Therapeutics' Retained Earnings stood at -$26.8 million in 2023, then soared by 246.44% to $39.3 million in 2024, then jumped by 47.03% to $57.7 million in 2025, then climbed by 0.72% to $58.1 million in 2026.
- Business Quant data shows SLXN's Retained Earnings at $58.1 million in Q1 2026, $57.7 million in Q4 2025, and -$50.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.38 Bn |
| 10 | Silexion Therapeutics | 266,692.97 | -1.96 Mn | - | -61.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -61.45 Mn |
| Mar 31, 2026 | 58.14 Mn |
| Dec 31, 2025 | 57.73 Mn |
| Sep 30, 2025 | -50.75 Mn |
| Jun 30, 2025 | 47.60 Mn |
| Mar 31, 2025 | 47.57 Mn |
| Dec 31, 2024 | 39.26 Mn |
| Sep 30, 2024 | 37.00 Mn |
| Jun 30, 2024 | 11.40 Mn |
| Dec 31, 2023 | -26.81 Mn |